However, tumor- IDO1/HLA-DR expression was most predictive of survival (OS, p=0.0005, HR = 0.4; PFS, p=0.0015, HR = 0.42), outperforming PD-L1 and INF-G signature. The gene discussed is CD274; the disease is neoplasm.